Treating cancer patients: Practical monitoring and management of therapy-related complications

Canadian Family Physician

Volumn 46, Issue NOV., 2000, Pages 2258-2268

  Brigden, Malcolm ^a   McKenzie, Michael ^b  

^a Penticton Regional Hospital   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; EYE DISEASE; FOLLOW UP; HUMAN; HYPOPHYSIS DISEASE; LUNG TOXICITY; LYMPHATIC SYSTEM DISEASE; NEUROLOGIC DISEASE; OVARY INSUFFICIENCY; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; SEPSIS; TESTIS DISEASE; THYROID DISEASE; TREATMENT PLANNING; UROGENITAL TRACT DISEASE; VASCULAR DISEASE;

ANTINEOPLASTIC AGENTS; HUMANS; NEOPLASMS; PRIMARY HEALTH CARE; RADIOTHERAPY;

EID: 0033637699     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Delaat CA, Lampkin BC. Long-term survivors of childhood cancer: evaluation and identification of treatment. CA Cancer J Clin 1992;42:263-82.
2. Connors JM. The cured lymphoma patients: guidelines for long-term follow up. Postgrad Med 1982;72:53-9.
3. Johnson FE, Virgo KS. Cancer patient follow-up. St Louis, Mo: Mosby-Year Book Inc; 1982.
4. Stierer M, Rosen HR. Influence of early diagnosis on prognosis of recurrent breast cancer. Cancer 1989;64:1128-31.
5. Virgo KS, Vernava AM, Longo WE, McKirgan LW, Johnson FE. Cost of patient followup after potentially curative colon cancer treatment. JAMA 1995;273:1837-41.
6. Walsh GL, O'Connor M, Willis KM, Milas M, Wong RS, Nesbitt JC. Is follow up of lung cancer patients following resection medically indicated and cost effective? Ann Thorac Surg 1995;60:1563-72.
7. Virgo KS, Naunheim KS, McKirgan LW, Kissling ME, Lin JC, Johnson FE. Cost of patient followup after potentially curative lung cancer treatment. J Thorac Cardiovasc Surg 1996;112:356-63.
8. Dailey MO, Coleman CN, Kaplan HS. Radiation-induced splenic atrophy in patients with Hodgkin's disease and non-Hodgkin's lymphomas. N Engl J Med 1980;302:215-7.
9. Brigden ML. Overwhelming postsplenectomy infection - still a problem. West J Med 1992;157:440-3.
10. Recommendations of the Immunization Practices Advisory Committee. Pneumococcal polysaccharide vaccine [review]. MMWR Morb Mortal Wkly Rep 1989;38:64-8,73-6.
11. Schultheiss TE, Kun LE, Ang KK, Stephens LC. Radiation response of the central nervous system. M J Radiat Oncol Biol Phys 1995;31(5):1093-112.
12. Gordon KB, Charm DH, Sagermanm RH. Late effects of radiation on the eye and ocular adnexa. Int J Radiat Oncol Phys 1995;31(5):1123-39.
13. Gillette EL, Mahler PA, Powers BE, Gillette SM, Vujaskovic Z. Late radiation injury to muscle and peripheral nerves [review]. Int J Radiat Oncol Biol Phys 1995;31(5):1309-18.
14. Chaudhry V, Rowinsky EK, Sartorius SE, Donehower RC, Cornblath DR. Peripheral neuropathy from Taxol and cisplatinum combination chemotherapy: clinical and electrophysiological studies. Ann Neurol 1994;35:304-11.
15. Fu KK, Kai EF, Leung CK. Cisplatin neuropathy: a prospective clinical and electrophysiological study in Chinese patients with ovarian carcinoma. J Clin Pharm Ther 1995;20:167-72.
16. Packer RJ, Meadows AT, Rorke LB, Goldwein JL, D'Angio G. Long-term sequelae of cancer treatment on the central nervous system in childhood [review]. Med Pediatr Oncol 1987;15:241-53.
17. Freilich RJ, Kraus DH, Budnick AS, Bayer LA, Finlay JL. Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue. Med Pediatr Oncol 1996;26:95-100.
18. Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 1991;325:599-605.
19. Sklar CA, Kim TH, Ramsay NK. Thyroid dysfunction among long-term survivors of bone marrow transplantation. Am J Med 1982;73:688-94.
20. Devney RB, Sklar CA, Nesbit ME, Kim TH, Williamson JF, Robison LL, et al. Serial thyroid function measurements in children with Hodgkin's disease. J Pediatr 1984;105:223-7.
21. Sklar CA, Constine LS. Chronic neuroendocrinological sequelae of radiation therapy [review]. Int J Radiat Oncol Biol Phys 1995;31(5):1113-21.
22. Beard CM, Heath H, O'Fallon M, Anderson JA, Earle JD, Melton LJD. Therapeutic radiation and hyperparathyroidism. Arch Intern Med 1989;149:1887-90.
23. Meirow D, Schenker JG. Cancer and male infertility. Hum Reprod 1995;10:2017-22.
24. rd ed. 1999. p. 457-537.
25. Pryzant RM, Meistrich ML, Wilson G, Brown B, McLaughlin P. Long-term reduction in sperm count after chemotherapy with and without radiation for non-Hodgkin's lymphoma. J Clin Oncol 1993;11:239-47.
26. Santoro A, Bonadonna GPV, Valagussa P, Zucali R, Viviani S, Pagnoni AM, et al. Long-term results of combined chemotherapy radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. J Clin Oncol 1989;5:27-37.
27. Rivkees SA, Crawford JD. The relationship of gonadal activity and chemotherapy induced gonadal damage. JAMA 1988;259:2123-5.
28. Horning SJ, Hoppe RT, Kaplan HS, Rosenberg SA. Female reproductive potential after treatment for Hodgkin's disease. N Engl J Med 1981;304:1377-82.
29. Wallace WHG, Shalet SM, Hendry JH, Morris-Jones PH, Gattamaneni HR. Ovarian failure following abdominal irradiation in childhood: the radiosensitivity of the human oocyte. Br J Radiol 1989;62:995-8.
30. Kreuser ED, Felsenberg D, Behles C, Seibt-Jung H, Mielcarek M, Diehl V, et al. Long-term gonadal dysfunction and its impact on bone mineralization in patients following COPP/ABVD chemotherapy for Hodgkin's disease. Ann Oncol 1992;3:105-10.
31. Mulvihill JJ, Myers MH, Connelly RR, Byrne J, Austin DF, Bragg K. Cancer in offspring of long-term survivors of childhood and adolescent cancer. Lancet 1987;2:813-7.
32. Green DM, Zevon MA, Lowrie G, Seigelstein N, Hall B. Congenital anomalies in children of patients who received chemotherapy for cancer in childhood and adolescence. N Engl J Med 1991;325:141-6.
33. McDonald S, Rubin P, Phillips TL. Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems. Int J Radiat Oncol Biol Phys 1995:31(5):1187-203.
34. Horning SJ, Adhikari A, Risk N, Hoppe RT, Olshen RA. Effect of treatment for Hodgkin's disease and pulmonary function: results of a prospective study. J Clin Oncol 1994;12:297-305.
35. Kreisman H, Wolkove N. Pulmonary toxicity of antineoplastic therapy [review]. Semin Oncol 1992;19:508-20.
36. O'Driscoll BR, Hasleton PS, Taylor PM, Poulter LW, Gattameneni HR, Woodcock AA. Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood. N Engl J Med 1990;323:378-82.
37. Bauer KA, Skarin AT, Balikian JP, Garnick MB, Rosenthal DS, Canellos GP. Pulmonary complications of chemotherapy regimens containing bleomycin. Am J Med 1983;74:557-63.
38. Stewart JR Fajardo LF, Gillette SM, Constine LS. Radiation injury to the heart. Int J Radiat Oncol Biol Phys 1995;31(5):1205-11.
39. Hancock SL, Donaldson SS, Hopper RT. Cardiac disease following treatment of Hodgkjn's disease in children and adolescents. J Clin Oncol 1993;11:1208-15.
40. Mittal B, Deutsch M, Thomspon M, Damesshek H. Radiation-induced accelerated coronary arteriosclerosis. Am J Med 1986;81:1843-4.
41. Petrek JA, Lerner. R Lymphedema. In: Harris JR, Lippman ME, Morrow M, Hellman S, editors. Diseases of the breast. Philadelphia, Pa: Lippincott-Raven; 1996. p. 896-903.
42. Berger CC, Bokemeyer C, Schneider M, Kuczyk MA, Schmoll HJ. Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer. Eur J Cancer 1995;1995(31A):2229-38.
43. Singal FK, Iliskovic N. Doxorubicin-induced cardiomyopathy [review]. N Engl J Med 1998;339(13):900-5.
44. Steinherz LJ, Steinherz PG, Tan CT, Heller G, Murphy ML. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA 1991;266:1672-7.
45. Postma A, Bink-Boelkens MT, Beaufort-Kfrol GC, Kengen RA, Elzenga NJ, Schasfoort-van Leeuwen MJ. Late cardiotoxicity after treatment for a malignant bone tumor. Med Pediatr Oncol 1996;26:230-7.
46. Cooper JS, Fu K, Marks J, Silverman J. Late effects of radiation therapy in the head and neck region. Int J Radiat Oncol Biol Phys 1995;31(5):1141-64.
47. McKenzie MR, Wong FLW, Epstein JP, Lepawsky M. Hyperbaric oxygen and postradiation osteonecrosis of the mandible. Oral Oncol Eur J Cancer 1993;29B(3):201-7.
48. Coia LR, Myerson RJ, Tepper JE. Late effects of radiation therapy on the gasiroin-testinal tract. Int J Radiat Oncol Biol Phys 1995;31(5):1213-36.
49. Lawrence TS, Robertson JM, Anscher MS, Jirtle RL, Ensminger WD, Fajardo LF. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 1995;31(5):1237-48.
50. Perry MC. Chemotherapeutic agents and hepatotoxicin. Semin Oncol 1992;19:551-65.
51. Parker D, Bate CM, Craft AW. Liver damage in children with acute leukemia and non-Hodgkin's lymphoma on oral maintenance chemotherapy. Cancer Chemother Pharmacol 1980;4:121-7.
52. Locasciulli A, Vergani GM, Uderzo C, Jean G, Cattaneo M, Vergani D, et al. Chronic liver disease in children with leukemia in long-term remission. Cancer 1983;52:1080-7.
53. Cassady JR. Clinical radiation nephropathy. Int J Radiat Oncol Biol Phys 1995;31(5):1249-56.
54. Marks LB, Carroll PR, Dugan TC, Anscher MS. The response of the urinary bladder, urethra and ureter to radiation and chemotherapy. Int J Radiat Oncol Bio Phys 1995;31(5):1257-80.
55. Patterson WP, Ream SGP. Renal toxicity of chemotherapy. Semin Oncol 1992;19:521-8.
56. Rossi R, Danzebrink S, Hillebrand D, Linnenburger K, Ullrich K, Jurgens H Ifosfamide induced subclinical nephrotoxicity and its potentiation by cisplatinum. Med Pediatr Oncol 1994;22:27-32.
57. Pedersen-Bjergaard J, Ersboll J, Hansen VL. Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma. N Engl J Med 1988;318:1028-32.
58. Robitaille P, Mongeau JG, Lortie L, Sinnassamy P. Long-term followup of patients who underwent unilateral nephrectomy in childhood. Lancet 1985;1:1297-9.
59. Fu AL, Greven KM, Maruyam Y. Radiation osteitis and insufficiency fractures after pelvic irradiation for gynecologic malignancies. Am J Clin Oncol 1994;17(3):1297-9.
60. Hall EJ. Radiation carcinogenesis. In: Radiobiology for the radiologist. Philadelphia, Pa: Lippincott; 1994. p. 323-50.
61. Pui CH, Ribiero RC, Hancock ML, Rivera GK, Evans WE, Raimondi SC. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 1991;325:1682-7.
62. Ballen KK, Antin JH. Treatment of therapy-related acute myelogenous leukemia and myelodysplastic syndromes [review]. Hematol-Oncol Clin North Ant 1993;7:477-93.
63. Tucker MA, Coleman CN, Cox RS, Varghese A, Rosenberg SA. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 1988;318:76-81.